Sliwkowski, Mark X.
Genentech, Inc,
United States
2024 Rank: 49069
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 2114 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 49069 | 56699 |
| Total Cites | 26906 | 28104 |
| H-index | 60 | 62 |
| Hm-index | 15 | 16 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 39 | 40 |
| Number of Single+First Authored Papers | 5 | 5 |
| Total Cites to Single+First Authored Papers | 1658 | 1709 |
| Number of Single+First+Last Authored Papers | 39 | 39 |
| Total Cites to Single+First+Last Authored Papers | 14274 | 14702 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 18805 | 19285 |
| Ratio of Total Citations to Distinct Citing Papers | 1.43 | 1.46 |
| Self-Citation Percentage |
4.26%
|
|
Sliwkowski, Mark X.
Genentech, Inc,
United States
2023 Rank: 46054
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 2017 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 46054 | 53418 |
| Total Cites | 25805 | 26995 |
| H-index | 60 | 62 |
| Hm-index | 15 | 16 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 37 | 38 |
| Number of Single+First Authored Papers | 5 | 5 |
| Total Cites to Single+First Authored Papers | 1614 | 1665 |
| Number of Single+First+Last Authored Papers | 39 | 39 |
| Total Cites to Single+First+Last Authored Papers | 13739 | 14161 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 17928 | 18404 |
| Ratio of Total Citations to Distinct Citing Papers | 1.44 | 1.47 |
| Self-Citation Percentage |
4.41%
|
|
Sliwkowski, Mark X.
Genentech Incorporated,
United States
2022 Rank: 43818
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 1947 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 43818 | 50988 |
| Total Cites | 24467 | 25635 |
| H-index | 59 | 61 |
| Hm-index | 15 | 15 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 32 | 33 |
| Number of Single+First Authored Papers | 5 | 5 |
| Total Cites to Single+First Authored Papers | 1558 | 1609 |
| Number of Single+First+Last Authored Papers | 39 | 39 |
| Total Cites to Single+First+Last Authored Papers | 13053 | 13466 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 16906 | 17370 |
| Ratio of Total Citations to Distinct Citing Papers | 1.45 | 1.48 |
| Self-Citation Percentage |
4.56%
|
|
Sliwkowski, Mark X.
Genentech Incorporated,
United States
2021 Rank: 42148
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 1878 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 42148 | 49076 |
| Total Cites | 23743 | 24908 |
| H-index | 58 | 60 |
| Hm-index | 15 | 15 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 31 | 32 |
| Number of Single+First Authored Papers | 5 | 5 |
| Total Cites to Single+First Authored Papers | 1526 | 1577 |
| Number of Single+First+Last Authored Papers | 39 | 39 |
| Total Cites to Single+First+Last Authored Papers | 12682 | 13099 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 16408 | 16868 |
| Ratio of Total Citations to Distinct Citing Papers | 1.45 | 1.48 |
| Self-Citation Percentage |
4.68%
|
|
Sliwkowski, Mark X.
Genentech Incorporated,
United States
2020 Rank: 38656
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 1812 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 38656 | 44981 |
| Total Cites | 22218 | 23367 |
| H-index | 57 | 59 |
| Hm-index | 15 | 15 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 30 | 31 |
| Number of Single+First Authored Papers | 5 | 5 |
| Total Cites to Single+First Authored Papers | 1470 | 1522 |
| Number of Single+First+Last Authored Papers | 39 | 39 |
| Total Cites to Single+First+Last Authored Papers | 11888 | 12302 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 15280 | 15730 |
| Ratio of Total Citations to Distinct Citing Papers | 1.45 | 1.49 |
| Self-Citation Percentage |
4.92%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.